1 Stanford JL,Bahr GM,Rook GA,el al.Immunotherapy with Mycobacterium vaccae as an adjunct to cheraontherapy in the treatment of pulmonary toberculosis[J].Tubercle, 1990,7l(2):87-93
2 罗永艾.微卡的临床疗效及安全性[J].临床肺科杂志,2002,7(3):封3
3 全国微卡菌苗临床研究协作组.母牛分枝杆菌菌苗在初治肺结核治疗中的作用[J].中华结核和呼吸杂志 2001,24(01):44-48
4 Stanford J,Stanford C,Grange J.Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis [J].Frontiers in Bioscience,2004,9:1701-1719
5 Zuany-Amorimi C,Sawicka E,Manlius C,et al.Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells[J].Natrure Medicine, 2002,8(6):625-629
6 庄玉辉,王国治,李晓明,等.母牛分枝杆菌制剂对T淋巴细胞增殖反应影响的研究[J].微生物学报,1995,35:292-297
7 李晓明,王国治,赵桂芳,等.母牛分枝杆菌制剂对小鼠腹腔巨噬细胞产生H202水平的影响[J].中国防痨杂志,1996,18(01):23-24
8 王国治,赵桂芳,李晓明,等.母牛分枝杆菌制剂通过一氧化氮进行免疫调节[J].中华结核和呼吸杂志,1996,19(03):13-15
9 王国治,赵桂芳,沈小兵,等.无细胞母牛分枝杆菌疫苗的研究与应用[J].中国防痨杂志,2000,22(5):14-18
10 Hernandez-Pando R,Pavo L,Arriaga K,et al.Pathogenesis of Tuberculosis in Mice Exposed to Low and High Doses of an Environmental Mycobacterial Saprophyte before Infection[J].Infection and Immunity,1997,65(8):3317-3327
11 饶高峰,吴高达.微卡7人9次副反应报告[J].临床肺科杂志,2005,10(1):109
12 陈树忠.微卡致过敏性休克1例[J].广东医药杂志,2002,23(7):710
13 Guy di Bruyn.Mycobacterium vaccae immunotherapy for treating tuber-culosis[J].The Cochrane collaboration,2005:2
14 卢水华,刘志成,等.母牛分枝杆菌菌苗免疫治疗肺结核临床观察2年随防结果[J].中国防痨杂志,2002,24(6):324-326
15 罗永艾,卢水华,郭述良,等.母牛分枝杆菌菌苗在难治性肺结核治疗中的作用[J].中华结核呼吸杂志,2002,25(1):21-24
16 宋小冬,任彦薇,朱虹,等.微卡方案治疗耐多药肺结核36例疗效观察[J].中国综合临床,2002,18(11):1006
17 杨祖六,段连山,关砚生,等.微卡预防尘肺并发结核的实验研究[J].中华结核和呼吸杂志,1997,20(06):30-33
18 黄重敏,黄其文,覃亚勤,等.采用母牛分枝杆菌预防糖尿病患者并发肺结核的临床观察[J].第三军医大学学报,2004,26(16):1476-1478
19 孙燕芝,顾美红,李少珍,等.母牛分枝杆菌疫苗对PPD强阳性者预防性治疗效果[J].中国生物制品学杂志2004,17(4):249-250
20 刘元东,靳晓红,李健,等.结核菌感染者微卡菌苗预防作用的研究[J].中国防痨杂志,2000,22(4):46-47
21 Johnsona D,Waddellb RD,Peltonc SL,et al.Randomised trial of intradermal Mycobacterium vaccae or intradermal hepatitis B immunisation in children with HIV infection[J]. Vaccine,1999,17:2583-2587
22 Waddell RD,et al,Safety and Immunogenicity of a Five-Dose Series of Inactivated Mycobacterium vaccae Vaccination for the Prevention of HFV-Associated Tuberculosis [J].Clinical Infectious Diseases 2000,30(S 3):309-315
|